Brooklyn District Attorney Eric Gonzalez – Innovative Approach to Safety
JONES DAY TALKS®: Women in IP – AI and Copyright Law Need-to-Knows
Hilary Preston, Vice Chair at Vinson & Elkins, Discusses Energy Innovation: Protecting Your Intellectual Property Portfolio
Taking the Pulse, A Health Care and Life Sciences Video Podcast | Episode 228: Designing & Manufacturing Auto-Injectors with Kimberlee Steele of SHL Medical
Innovation in Compliance: Visionary Leadership with Jackson Calame
A Thermal Storage Revolution With Nis Benn, Hyme Energy — Battery + Storage Podcast
Taking the Pulse, A Health Care and Life Sciences Video Podcast | Episode 225: Cancer Care Access & Treatments with Dr. Sengar of Alabama Cancer Care
Building a Business at the Intersection of Neurodata and Innovation With Rob Cooley
Approach to Responsible AI
Creating Impact Through Innovation: Brandon Kashani on Leading Mission-Driven Startups
Bridging the Gap: How CivicReach is Revolutionizing Government Customer Service
Podcast — Drug Pricing: 2025 J.P. Morgan Healthcare Conference Takeaways and Outlook
Podcast — UK FinReg Focus Areas in 2025: Sectoral Trends
Taking the Pulse, A Health Care and Life Sciences Video Podcast | Episode 218: Artificial Intelligence in Drug Development with John Van Hoy of PPD & Thermo Fisher
Driving Towards Greater Transparency and Sustainability in the EV Market with Davide Giacobbe and ScoutIt
Crafting an Effective Law Firm Generative AI Policy for Responsible Business Use: On Record PR
The Privacy Insider Podcast Episode 9: I Think, Therefore I Am: AI, Ethics, & Humanity With Dr. Michael Hemenway
Can You Copyright AI-Generated Content? - On Record PR
Harnessing Generative AI: Innovations and Best Practices — The Good Bot Podcast
Harnessing Technology in Litigation: Insights from Troutman Pepper eMerge - Energy Law Insights
The US Food and Drug Administration (FDA) recently announced a strategic roadmap to phase out animal testing requirements for certain drug products, starting with monoclonal antibodies. This shift marks a significant change...more
On January 23, 2025, as one of the first actions of his second term, President Trump signed Executive Order (EO) 14179, “Removing Barriers to American Leadership in Artificial Intelligence,” making good on a campaign promise...more
To help you stay on top of the latest news, our AI practice group has compiled a roundup of the developments we are following....more
Since 1995, Nature Medicine has been chronicling advances in medical technology and health care. To mark the journal’s 30th anniversary, each month an issue of critical importance for the future of medicine will be...more
Investment in artificial intelligence (AI) is rising fast. The International Data Corporation projects global spending on AI R&D will reach $632 billion by 2028, more than twice the expected total for 2024....more
This blog post discusses the EU Artificial Intelligence Act’s (“AI Act”) measures in support of innovation. These measures will be particularly relevant for companies engaged in research and development activities....more
Artificial Intelligence (AI) has emerged as a major player in the realm of health care, promising to completely transform its delivery. With AI’s remarkable ability to analyze data, learn, solve problems, and make decisions,...more
Overview - Artificial Intelligence (AI) continues to drive dialogue among policy makers, industry leaders, and the broader public and presents increasing congressionally authorized federal spending opportunities. For decades,...more
On May 23, the Biden Administration announced several new initiatives to support the development of a National Artificial Intelligence (AI) Strategy. The initiatives focus on: (1) outlining a plan to increase federal...more